Why the study?
Does intravenous amiodarone alter the H-V interval in patients with intraventricular conduction disorders?
Does intravenous amiodarone alter the H-V interval in patients with intraventricular conduction disorders?
Intravenous amiodarone appears safe in patients with bundle branch block as it does not significantly prolong the H-V interval despite other electrophysiological effects.
Answers are grounded in this paper and cite their sources.
May support IV amiodarone safety in bundle branch block; leaves open need for larger prospective studies in conduction disorders.
Using His bundle recordings and stimulation techniques, the electrical effects of amiodarone (5 mg/kg intravenously) were assessed in 12 patients aged 34–80 years (mean 65) exhibiting in sinus rhythm, intraventricular conduction disturbances. Bundle branch block was present in 10 patients: left bundle branch block in three patients, right bundle branch block in three, bilateral bundle branch block in four. All the patients had a long H-V interval (65–80 ms; mean 71). As has been previously reported, amiodarone slowed the sinus rate, prolonged the QT interval, increased the atrial effective refractory period and depressed A-V nodal conduction. Despite the presence of advanced conduction disturbances within the His-Purkinje system, amiodarone did not alter the H-V interval in 11 patients and increased it in one by only 5 ms. Thus, clinically, the use of amiodarone in patients with bundle branch block should be safe.
No takes yet. Share an insight, caveat, or question.
Touboul et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: